JHS Svendgaard Laboratories Ltd
JHS Svendgaard Laboratories Ltd (JHS) last traded at ₹9.01, a market capitalisation of ₹79.5 crore. Over the past 52 weeks the stock has ranged between ₹6.15 and ₹13.9. JHS Svendgaard Laboratories Ltd last reported results for the quarter ended Jun 2026, with sales of ₹30.38 crore and net profit of ₹1.09 crore. Figures are as of 24 Aug 2026 and are not real time.
JHS Svendgaard Laboratories Ltd share price and key metrics
Metrics as of 24 Aug 2026. Not real time.
JHS Svendgaard Laboratories Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹30.38 cr, up 29.6% from ₹23.45 cr a year earlier. Net profit was ₹1.09 cr, up 2.8% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 19.68 | 22.66 | 25.17 | 23.45 | 22.28 | 23.27 | 32.7 | 30.38 |
| Expenses | 20.52 | 22.41 | 30.55 | 21.79 | 21.37 | 21.6 | 34.34 | 28.31 |
| Operating profit | -0.84 | 0.25 | -5.38 | 1.66 | 0.91 | 1.67 | -1.64 | 2.07 |
| OPM % | -4.27% | 1.10% | -21.37% | 7.08% | 4.08% | 7.18% | -5.02% | 6.81% |
| Other income | 0.86 | 0.27 | -1.44 | 1 | 1.14 | 0.59 | 0.73 | 0.09 |
| Interest | 0.11 | 0.13 | 0.21 | 0.16 | 0.2 | 0.28 | 0.22 | 0.28 |
| Depreciation | 1.98 | 1.97 | 2.02 | 1.88 | 1.86 | 1.9 | 1.86 | 1.82 |
| Profit before tax | -2.07 | -1.58 | -9.05 | 0.62 | -0.01 | 0.08 | -2.99 | 0.06 |
| Tax % | 398.07% | 15.82% | -23.09% | -69.35% | 1,800.00% | -887.50% | 19.73% | -1,716.67% |
| Net profit | -10.32 | -1.84 | -6.96 | 1.06 | -0.2 | 0.79 | -3.57 | 1.09 |
| EPS (₹) | -1.21 | -0.21 | -0.81 | 0.12 | -0.02 | 0.09 | -0.41 | 0.12 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
JHS Svendgaard Laboratories Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 101 | 86 | 85 | 71 | 92 | 102 | 109 |
| Operating profit | 2 | -1 | -9 | -1 | -4 | 3 | 3 |
| OPM % | 1.9% | -1.0% | -11% | -1.3% | -4.4% | 2.6% | 2.8% |
| Net profit | 1 | -4 | -18 | -4 | -20 | -2 | -2 |
| EPS (₹) | 0.19 | -0.62 | 0.62 | -0.52 | -2.31 | -0.22 | -0.22 |
TTM is the trailing twelve months to the most recent quarter.
JHS Svendgaard Laboratories Ltd growth and returns
- 10 Years
- 0%
- 5 Years
- 0%
- 3 Years
- 6%
- TTM
- 19%
- 10 Years
- 4%
- 5 Years
- %
- 3 Years
- %
- TTM
- 88%
- 10 Years
- -12%
- 5 Years
- -17%
- 3 Years
- -29%
- 1 Year
- -17%
- 10 Years
- 2%
- 5 Years
- -1%
- 3 Years
- -5%
- Last Year
- -1%
JHS Svendgaard Laboratories Ltd shareholding pattern
Promoters held 33.85% at Jun 2026, down from 34.56% at Jun 2025. FIIs 3.14% and DIIs 0.00%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 34.56% | 34.56% | 34.56% | 34.56% | 34.56% | 34.56% | 33.85% | 33.85% |
| FIIs | 1.69% | 1.59% | 1.60% | 1.59% | 1.57% | 1.57% | 3.60% | 3.14% |
| DIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 63.76% | 63.85% | 63.84% | 63.86% | 63.87% | 63.86% | 62.57% | 63.03% |
| No. of shareholders | 25,994 | 26,276 | 25,567 | 25,155 | 25,007 | 25,151 | 25,330 | 25,150 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
JHS Svendgaard Laboratories Ltd corporate filings
- Newspaper Publication of Un- Audited Financial Results for the Quarter Ended June 30, 2026.Company Updatehigh impact
Cruxal's analysis: JHS Svendgaard Laboratories Limited has released its unaudited financial results for the…
Read the full analysis - Statement of Deviation and Variation for the Quarter Ended 30th June, 2026Company Updatelow impact
Cruxal's analysis: The company has submitted its Statement of Deviation and Variation for the quarter ended…
Read the full analysis - The Board of Directors in its meeting held on 11th August, 2026 inter alia Considered and Approved the Un-Audited Financial Results for the Quarter Ended 30th June, 2026Resulthigh impact
Cruxal's analysis: JHS Svendgaard Laboratories Limited reported a turnaround in its financial performance…
Read the full analysis - JHS Svendgaard Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve Un-Audited Financial ....Board Meetinglow impact
Cruxal's analysis: JHS Svendgaard Laboratories Limited has issued a formal intimation regarding a Board of…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track JHS Svendgaard Laboratories Ltd
Cruxal reads every JHS Svendgaard Laboratories Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.